Haymarket Medical Network Launches Rare Disease Advisor

New website provides information for care teams in every specialty

NEW YORK--(BUSINESS WIRE)--Haymarket Medical Network today launched Rare Disease Advisor, a new digital resource for healthcare professionals (HCPs) to help them recognize, diagnose, refer and treat rare diseases.

RareDiseaseAdvisor.com fills an information gap for HCPs by providing difficult to find information on rare diseases in one convenient place, enabling physicians and care teams with a comprehensive digital resource that will empower them to improve patient outcomes. The site’s thorough approach to covering rare disease news and perspectives will also benefit patients by providing them with up-to-date and relevant information that allows them to advocate for themselves and their families.

RareDiseaseAdvisor.com will employ a multi-content, multi-channel approach to engage readers with relevant, authoritative news, perspectives and disease information, including feature articles, daily news briefings, conference and drug launch coverage, and much more, offering the same timely and high quality information that clinicians have come to expect from the Haymarket Medical Network.

"Patients suffering from rare medical conditions often struggle to be properly diagnosed. I am excited that Rare Disease Advisor will inform HCPs on the innovative therapies being developed and help connect underserved patients to treatment,” said Mike Graziani, President, Haymarket Medical Communications Group. “We look forward to providing HCPs and the entire care team with the best clinical information and tools."

The first 13 rare diseases to be focused on, organized as “Junctions,” include:

• Spinal Muscular Atrophy (SMA),
• Idiopathic Pulmonary Fibrosis (IPF),
• Medullary Thyroid Carcinoma (MTC),
• Pulmonary Arterial Hypertension (PAH),
• Gastrointestinal Stromal Tumor (GIST),
• Duchenne Muscular Dystrophy (DMD),
• Alagille Syndrome (ALGS),
• Lysosomal Acid Lipase Deficiency (LAL-D),
• Alpha-1 Antitrypsin Deficiency (AATD),
• Long Chain Fatty Acid Oxidation Disorder (LCFAOD),
• Cholangiocarcinoma (CC),
• Multiple Sclerosis (MS), and
• Pompe disease (PD).

For more information or sponsorship opportunities, contact Mike Nace, Brand Director.

About Haymarket Medical Network

Haymarket Medical Network reaches healthcare practitioners through a multichannel environment that includes more than a dozen unique brands offered across multiple formats - web, app, print and live events. Its inter-connectivity allows users to move from brand to brand to discover the relevant content they need to make practice-related decisions. Included in the network is renowned drug database MPR, continuing medical education company myCME, as well as an expanding portfolio of websites that deliver news and feature content targeting specific therapeutic areas such as Cardiology Advisor, Infectious Disease Advisor, Oncology Nurse Advisor and more. To learn more, visit www.haymarketmedicalnetwork.com.